PDE5A and prostate carcinoma: Finally, in a study performed by Hankey et al., in prostate cancer cell lines, the authors demonstrated that the treatment with PDE5i at clinically relevant concentrations did not induce variation in the proliferation, colony formation or migration phenotypes, even when cells were co-treated with a stimulator of cGMP synthesis to facilitate cGMP accumulation upon PDE5 inhibition.